Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1995 May;95(5):2047–2053. doi: 10.1172/JCI117890

Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia.

A Arnold 1, M F Brown 1, P Ureña 1, R D Gaz 1, E Sarfati 1, T B Drüeke 1
PMCID: PMC295791  PMID: 7738171

Abstract

The pathogeneses of parathyroid disease in patients with uremia and nonfamilial primary parathyroid hyperplasia are poorly understood. Because of multigland involvement, it has been assumed that these common diseases predominantly involve polyclonal (non-neoplastic) cellular proliferations, but an overall assessment of their clonality has not been done. We examined the clonality of these hyperplastic parathyroid tumors using X-chromosome inactivation analysis with the M27 beta (DXS255) DNA polymorphism and by searching for monoclonal allelic losses at M27 beta and at loci on chromosome band 11q13. Fully 7 of 11 informative hemodialysis patients (64%) with uremic refractory hyperparathyroidism harbored at least one monoclonal parathyroid tumor (with a minimum of 12 of their 19 available glands being monoclonal). Tumor monoclonality was demonstrable in 6 of 16 informative patients (38%) with primary parathyroid hyperplasia. Histopathologic categories of nodular versus generalized hyperplasia were not useful predictors of clonal status. These observations indicate that monoclonal parathyroid neoplasms are common in patients with uremic refractory hyperparathyroidism and also develop in a substantial group of patients with sporadic primary parathyroid hyperplasia, thereby changing our concept of the pathogenesis of these diseases. Neoplastic transformation of preexisting polyclonal hyperplasia, apparently due in large part to genes not yet implicated in parathyroid tumorigenesis and possibly including a novel X-chromosome tumor suppressor gene, is likely to play a central role in these disorders.

Full text

PDF
2047

Images in this article

2049Image
on p.2049
2050Image
on p.2050
2050Image
on p.2050
2050Image
on p.2050

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnold A., Kim H. G., Gaz R. D., Eddy R. L., Fukushima Y., Byers M. G., Shows T. B., Kronenberg H. M. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest. 1989 Jun;83(6):2034–2040. doi: 10.1172/JCI114114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnold A., Staunton C. E., Kim H. G., Gaz R. D., Kronenberg H. M. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med. 1988 Mar 17;318(11):658–662. doi: 10.1056/NEJM198803173181102. [DOI] [PubMed] [Google Scholar]
  3. Biller B. M., Alexander J. M., Zervas N. T., Hedley-Whyte E. T., Arnold A., Klibanski A. Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. J Clin Endocrinol Metab. 1992 Nov;75(5):1303–1309. doi: 10.1210/jcem.75.5.1358909. [DOI] [PubMed] [Google Scholar]
  4. Boyd Y., Fraser N. J. Methylation patterns at the hypervariable X-chromosome locus DXS255 (M27 beta): correlation with X-inactivation status. Genomics. 1990 Jun;7(2):182–187. doi: 10.1016/0888-7543(90)90539-7. [DOI] [PubMed] [Google Scholar]
  5. Brown E. M., Gamba G., Riccardi D., Lombardi M., Butters R., Kifor O., Sun A., Hediger M. A., Lytton J., Hebert S. C. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature. 1993 Dec 9;366(6455):575–580. doi: 10.1038/366575a0. [DOI] [PubMed] [Google Scholar]
  6. Brown R. M., Fraser N. J., Brown G. K. Differential methylation of the hypervariable locus DXS255 on active and inactive X chromosomes correlates with the expression of a human X-linked gene. Genomics. 1990 Jun;7(2):215–221. doi: 10.1016/0888-7543(90)90543-4. [DOI] [PubMed] [Google Scholar]
  7. Cengiz K., Block A. M., Hossfeld D. K., Anthone R., Anthone S., Sandberg A. A. Sister chromatid exchange and chromosome abnormalities in uremic patients. Cancer Genet Cytogenet. 1988 Nov;36(1):55–67. doi: 10.1016/0165-4608(88)90075-1. [DOI] [PubMed] [Google Scholar]
  8. Falchetti A., Bale A. E., Amorosi A., Bordi C., Cicchi P., Bandini S., Marx S. J., Brandi M. L. Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11. J Clin Endocrinol Metab. 1993 Jan;76(1):139–144. doi: 10.1210/jcem.76.1.8421078. [DOI] [PubMed] [Google Scholar]
  9. Fearon E. R., Hamilton S. R., Vogelstein B. Clonal analysis of human colorectal tumors. Science. 1987 Oct 9;238(4824):193–197. doi: 10.1126/science.2889267. [DOI] [PubMed] [Google Scholar]
  10. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  11. Fey M. F., Peter H. J., Hinds H. L., Zimmermann A., Liechti-Gallati S., Gerber H., Studer H., Tobler A. Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe. J Clin Invest. 1992 May;89(5):1438–1444. doi: 10.1172/JCI115733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fialkow P. J. Clonal origin of human tumors. Biochim Biophys Acta. 1976 Oct 12;458(3):283–321. doi: 10.1016/0304-419x(76)90003-2. [DOI] [PubMed] [Google Scholar]
  13. Fraser N. J., Boyd Y., Craig I. Isolation and characterization of a human variable copy number tandem repeat at Xcen-p11.22. Genomics. 1989 Jul;5(1):144–148. doi: 10.1016/0888-7543(89)90099-2. [DOI] [PubMed] [Google Scholar]
  14. Friedman E., Sakaguchi K., Bale A. E., Falchetti A., Streeten E., Zimering M. B., Weinstein L. S., McBride W. O., Nakamura Y., Brandi M. L. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med. 1989 Jul 27;321(4):213–218. doi: 10.1056/NEJM198907273210402. [DOI] [PubMed] [Google Scholar]
  15. Fukuda N., Tanaka H., Tominaga Y., Fukagawa M., Kurokawa K., Seino Y. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest. 1993 Sep;92(3):1436–1443. doi: 10.1172/JCI116720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gagné E. R., Ureña P., Leite-Silva S., Zingraff J., Chevalier A., Sarfati E., Dubost C., Drüeke T. B. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol. 1992 Oct;3(4):1008–1017. doi: 10.1681/ASN.V341008. [DOI] [PubMed] [Google Scholar]
  17. Gicquel C., Le Bouc Y., Luton J. P., Girard F., Bertagna X. Monoclonality of corticotroph macroadenomas in Cushing's disease. J Clin Endocrinol Metab. 1992 Aug;75(2):472–475. doi: 10.1210/jcem.75.2.1322426. [DOI] [PubMed] [Google Scholar]
  18. Harach H. R., Jasani B. Parathyroid hyperplasia in tertiary hyperparathyroidism: a pathological and immunohistochemical reappraisal. Histopathology. 1992 Dec;21(6):513–519. doi: 10.1111/j.1365-2559.1992.tb00438.x. [DOI] [PubMed] [Google Scholar]
  19. Hendriks R. W., Hinds H., Chen Z. Y., Craig I. W. The hypervariable DXS255 locus contains a LINE-1 repetitive element with a CpG island that is extensively methylated only on the active X chromosome. Genomics. 1992 Nov;14(3):598–603. doi: 10.1016/s0888-7543(05)80157-0. [DOI] [PubMed] [Google Scholar]
  20. Hendriks R. W., Kraakman M. E., Mensink R. G., Schuurman R. K. Differential methylation at the 5' and the 3' CCGG sites flanking the X chromosomal hypervariable DXS255 locus. Hum Genet. 1991 Nov;88(1):105–111. doi: 10.1007/BF00204939. [DOI] [PubMed] [Google Scholar]
  21. Herman V., Fagin J., Gonsky R., Kovacs K., Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab. 1990 Dec;71(6):1427–1433. doi: 10.1210/jcem-71-6-1427. [DOI] [PubMed] [Google Scholar]
  22. Hicks D. G., LiVolsi V. A., Neidich J. A., Puck J. M., Kant J. A. Clonal analysis of solitary follicular nodules in the thyroid. Am J Pathol. 1990 Sep;137(3):553–562. [PMC free article] [PubMed] [Google Scholar]
  23. Hodges E., Howell W. M., Boyd Y., Smith J. L. Variable X-chromosome DNA methylation patterns detected with probe M27 beta in a series of lymphoid and myeloid malignancies. Br J Haematol. 1991 Mar;77(3):315–322. doi: 10.1111/j.1365-2141.1991.tb08577.x. [DOI] [PubMed] [Google Scholar]
  24. Jacoby L. B., Hedley-Whyte E. T., Pulaski K., Seizinger B. R., Martuza R. L. Clonal origin of pituitary adenomas. J Neurosurg. 1990 Nov;73(5):731–735. doi: 10.3171/jns.1990.73.5.0731. [DOI] [PubMed] [Google Scholar]
  25. Le Charpentier Y., Dubost C., Ferrand J., Lavergne A., Liard M. E., Skrobala E., Wassef M. Hyperparathyroïdies primitives. Technique d'examen et étapes du diagnostic des lésions parathyroïdiennes. Arch Anat Cytol Pathol. 1983;31(1):49–62. [PubMed] [Google Scholar]
  26. Malachi T., Zevin D., Gafter U., Chagnac A., Slor H., Levi J. DNA repair and recovery of RNA synthesis in uremic patients. Kidney Int. 1993 Aug;44(2):385–389. doi: 10.1038/ki.1993.256. [DOI] [PubMed] [Google Scholar]
  27. Motokura T., Bloom T., Kim H. G., Jüppner H., Ruderman J. V., Kronenberg H. M., Arnold A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature. 1991 Apr 11;350(6318):512–515. doi: 10.1038/350512a0. [DOI] [PubMed] [Google Scholar]
  28. Nakamura Y., Gillilan S., O'Connell P., Leppert M., Lathrop G. M., Lalouel J. M., White R. Isolation and mapping of a polymorphic DNA sequence pHBI59 on chromosome 11 [D11S146]. Nucleic Acids Res. 1988 Jan 11;16(1):376–376. doi: 10.1093/nar/16.1.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nakamura Y., Larsson C., Julier C., Byström C., Skogseid B., Wells S., Oberg K., Carlson M., Taggart T., O'Connell P. Localization of the genetic defect in multiple endocrine neoplasia type 1 within a small region of chromosome 11. Am J Hum Genet. 1989 May;44(5):751–755. [PMC free article] [PubMed] [Google Scholar]
  30. Namba H., Matsuo K., Fagin J. A. Clonal composition of benign and malignant human thyroid tumors. J Clin Invest. 1990 Jul;86(1):120–125. doi: 10.1172/JCI114673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Parfitt A. M., Braunstein G. D., Katz A. Radiation-associated hyperparathyroidism: comparison of adenoma growth rates, inferred from weight and duration of latency, with prevalence of mitosis. J Clin Endocrinol Metab. 1993 Nov;77(5):1318–1322. doi: 10.1210/jcem.77.5.8077327. [DOI] [PubMed] [Google Scholar]
  32. Parfitt A. M. Hypercalcemic hyperparathyroidism following renal transplantation: differential diagnosis, management, and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab. 1982 Aug;8(2):92–112. [PubMed] [Google Scholar]
  33. Rosenberg C. L., Kim H. G., Shows T. B., Kronenberg H. M., Arnold A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene. 1991 Mar;6(3):449–453. [PubMed] [Google Scholar]
  34. Schulte H. M., Oldfield E. H., Allolio B., Katz D. A., Berkman R. A., Ali I. U. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis. J Clin Endocrinol Metab. 1991 Dec;73(6):1302–1308. doi: 10.1210/jcem-73-6-1302. [DOI] [PubMed] [Google Scholar]
  35. Sidransky D., Frost P., Von Eschenbach A., Oyasu R., Preisinger A. C., Vogelstein B. Clonal origin bladder cancer. N Engl J Med. 1992 Mar 12;326(11):737–740. doi: 10.1056/NEJM199203123261104. [DOI] [PubMed] [Google Scholar]
  36. Steiner R. W., Ziegler M., Halasz N. A., Catherwood B. D., Manolagas S., Deftos L. J. Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients. Transplantation. 1993 Oct;56(4):843–846. doi: 10.1097/00007890-199310000-00013. [DOI] [PubMed] [Google Scholar]
  37. Thakker R. V., Bouloux P., Wooding C., Chotai K., Broad P. M., Spurr N. K., Besser G. M., O'Riordan J. L. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. N Engl J Med. 1989 Jul 27;321(4):218–224. doi: 10.1056/NEJM198907273210403. [DOI] [PubMed] [Google Scholar]
  38. Vogelstein B., Fearon E. R., Hamilton S. R., Feinberg A. P. Use of restriction fragment length polymorphisms to determine the clonal origin of human tumors. Science. 1985 Feb 8;227(4687):642–645. doi: 10.1126/science.2982210. [DOI] [PubMed] [Google Scholar]
  39. Yang-Feng T. L., Li S., Han H., Schwartz P. E. Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer. Int J Cancer. 1992 Oct 21;52(4):575–580. doi: 10.1002/ijc.2910520414. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES